Opportunities and Challenges in Phenotypic Screening for Neurodegenerative Disease Research
- PMID: 31268707
- DOI: 10.1021/acs.jmedchem.9b00797
Opportunities and Challenges in Phenotypic Screening for Neurodegenerative Disease Research
Abstract
Toxic misfolded proteins potentially underly many neurodegenerative diseases, but individual targets which regulate these proteins and their downstream detrimental effects are often unknown. Phenotypic screening is an unbiased method to screen for novel targets and therapeutic molecules and span the range from primitive model organisms such as Sacchaomyces cerevisiae, which allow for high-throughput screening to patient-derived cell-lines that have a close connection to the disease biology but are limited in screening capacity. This perspective will review current phenotypic models, as well as the chemical screening strategies most often employed. Advances in in 3D cell cultures, high-content screens, robotic microscopy, CRISPR screening, and use of machine learning methods to process the enormous amount of data generated by these screens are certain to change the paradigm for phenotypic screening and will be discussed.
Similar articles
-
A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?J Biomol Screen. 2015 Sep;20(8):1040-51. doi: 10.1177/1087057115590069. Epub 2015 Jun 5. J Biomol Screen. 2015. PMID: 26048892 Review.
-
CRISPR-Cas9 knockout screening for functional genomics.Sci China Life Sci. 2014 Jul;57(7):733-4. doi: 10.1007/s11427-014-4684-4. Epub 2014 Jun 10. Sci China Life Sci. 2014. PMID: 25005538 No abstract available.
-
Functional Genomics and High Content Screening in the Nervous System.Mol Cell Neurosci. 2017 Apr;80:159-160. doi: 10.1016/j.mcn.2017.03.009. Mol Cell Neurosci. 2017. PMID: 28413055 No abstract available.
-
High content screening in neurodegenerative diseases.J Vis Exp. 2012 Jan 6;(59):e3452. doi: 10.3791/3452. J Vis Exp. 2012. PMID: 22257990 Free PMC article.
-
Advances in technologies for 3D genomics research.Sci China Life Sci. 2020 Jun;63(6):811-824. doi: 10.1007/s11427-019-1704-2. Epub 2020 May 8. Sci China Life Sci. 2020. PMID: 32394244 Review.
Cited by
-
Development of Pharmacological Strategies with Therapeutic Potential in Ischemic Stroke.Antioxidants (Basel). 2023 Dec 12;12(12):2102. doi: 10.3390/antiox12122102. Antioxidants (Basel). 2023. PMID: 38136221 Free PMC article. Review.
-
Translating the Genome into Drugs.Acc Chem Res. 2023 Feb 21;56(4):489-499. doi: 10.1021/acs.accounts.2c00791. Epub 2023 Feb 9. Acc Chem Res. 2023. PMID: 36757774 Free PMC article.
-
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace.Brief Bioinform. 2021 Mar 22;22(2):1790-1818. doi: 10.1093/bib/bbaa034. Brief Bioinform. 2021. PMID: 32187356 Free PMC article. Review.
-
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer's Disease.Pharmaceuticals (Basel). 2022 Dec 14;15(12):1560. doi: 10.3390/ph15121560. Pharmaceuticals (Basel). 2022. PMID: 36559010 Free PMC article. Review.
-
High-Throughput Phenotypic Assay for Compounds That Influence Mitochondrial Health Using iPSC-Derived Human Neurons.SLAS Discov. 2021 Jul;26(6):811-822. doi: 10.1177/24725552211000671. Epub 2021 Mar 16. SLAS Discov. 2021. PMID: 33724077 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases